AMGEN Inc’s filing revealed that its Officer DEREK MILLER acquired Company’s shares for reported $0.15 million on Feb 18 ’25. In the deal valued at $292.56 per share,500 shares were bought.
Then, Gordon Murdo sold 8,771 shares, generating $2,585,644 in total proceeds. Upon selling the shares at $294.79, the EVP, Global Commercial Ops now owns 44,186 shares.
Before that, Gordon Murdo bought 8,771 shares. AMGEN Inc shares valued at $2,590,076 were divested by the Officer at a price of $295.30 per share.
A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in mid November with a ‘”a Peer perform”‘ rating. Citigroup began covering AMGN with “Neutral” recommendation on November 14, 2024. Bernstein started covering the stock on October 17, 2024. It rated AMGN as “an Outperform”.
Price Performance Review of AMGN
On Tuesday, AMGEN Inc [NASDAQ:AMGN] saw its stock jump 0.56% to $292.80. Over the last five days, the stock has lost -0.68%. AMGEN Inc shares have risen nearly 12.34% since the year began. Nevertheless, the stocks have risen 0.94% over the past one year. While a 52-week high of $346.85 was reached on 02/06/25, a 52-week low of $253.30 was recorded on 01/06/25. SMA at 50 days reached $275.25, while 200 days put it at $305.79.
Levels Of Support And Resistance For AMGN Stock
The 24-hour chart illustrates a support level at 290.09, which if violated will result in even more drops to 287.38. On the upside, there is a resistance level at 294.42. A further resistance level may holdings at 296.04. The Relative Strength Index (RSI) on the 14-day chart is 57.44, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.10, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 55.30%. Stochastics %K at 41.08% indicates the stock is a holding.
